Reliance Pharma Fund (D)

Reliance Pharma Fund (D)

Summary Info
Fund Name : Reliance Mutual Fund
Scheme Name : Reliance Pharma Fund (D)
AMC : Reliance Mutual Fund
Type : Open
Category : Equity - Pharma
Launch Date : 10-May-04
Fund Manager : Sailesh Raj Bhan
Net Assets (Rs. cr) : 691.60

NAV Details

NAV Date : 18-Jun-13
NAV [Rs.] : 44.2
Buy/Resale Price [Rs.] : 43.73
Sell/Repurchase Price [Rs.] : 44.17
Entry Load % : Nil
Exit Load % : NIL

NAV Chart

Graph: 1m |   3m |   6m |   1y |   3y

Performance(%)

* returns above 1 yr. are annualized

  1w 1m 3m 6m 1y 3y 5y Since INC
Scheme Returns [0.6] [3.5] 7.3 2.8 27.1 10.8 23.4 24.1
Category Avg [0.6] [3.3] 8.0 5.2 28.8 12.3 18.9 12.3
Category Best [0.3] [2.4] 9.5 8.0 33.9 15.9 23.4 24.2
Category Worst [0.8] [3.8] 7.3 2.8 27.0 10.9 14.0 1.6

Latest Payouts

  Dividends Bonus
Ratio 35 % NA
Date 11-Jan-13 NA

Investment Details

Tax Benefits : 112(1) 
Min. Investment(Rs.) : 5,000.00
Increm.Investment(Rs.) : 1.00

In & Out

In
Name of the Company No of shares
No fresh investments made in
Out
Name of the Company No of shares
No investments sold out

Fund Holdings

As on 31-May-2013

Asset TypeInstrument NameIndustryNet Assets
(%)
No of SharesMkt Value
(Cr.)
Equity & Equity related Investments
Equitydivi's laboratories ltdPharmaceuticals11.0700,00075.2
Equityranbaxy laboratories ltdPharmaceuticals9.21,400,00063.3
Equitysanofi india ltdPharmaceuticals9.2245,81062.8
Equitycipla ltdPharmaceuticals9.01,523,43961.7
Equitydr. reddy's laboratories ltdPharmaceuticals8.4285,10057.8
Equitysun pharma advanced research company ltdMiscellaneous7.13,906,29148.5
Equitysun pharmaceuticals industries ltdPharmaceuticals6.9500,00047.6
Equityglaxosmithkline pharmaceuticals ltdPharmaceuticals6.2187,90042.5
Equityindoco remedies ltdPharmaceuticals5.35,754,27836.3
Equityabbott india ltdPharmaceuticals4.5219,55030.9
Equityipca laboratories ltdPharmaceuticals4.5600,31930.5
Equityzydus wellness ltdFMCG3.6560,64524.9
Equitycadila healthcare ltdPharmaceuticals3.4300,35123.6
Equitybiocon ltdPharmaceuticals3.4800,00023.0
Equityglenmark pharmaceuticals ltdPharmaceuticals2.5350,00017.0
Equityfulford india ltdPharmaceuticals1.0110,9017.1
Equitylupin ltdPharmaceuticals0.990,0006.3
Equitymerck ltdPharmaceuticals0.996,6966.1
Equityunichem laboratories ltdPharmaceuticals0.7289,5744.9
Equityvimta labs ltdMiscellaneous0.1310,3130.6
Debt Investments
NCDdr. reddy's laboratories ltdAA+0.0318,6000.2
Cash & Cash Equivalent
CBLOcbloUR / N.A.2.4NA16.3
Net CA & Othersnet current assets-/-[0.4]NA[2.4]

My Watchlist

Key Information

Fund House: Reliance Mutual Fund
Incorporation Date : 24-Feb-1995
Total Assets Managed (Cr.) : 26,420.11
Trustee/s : S Santhanakrishnan
Chairman : N/A
CEO / MD : Mr. Sundeep Sikka
CIO : N/A
President : N/A
Director/s : Sushil C. Tripathi
Compliance Officer/s : Mr. Muneesh Sud
Investor Service Officer/s : Mr. Bhalchandra Joshi
Fund Manager/s : Sailesh Raj Bhan

Other Information

Auditors :  N/A
Registered Office : 11th & 12th floor, One Indiabulls ,Centre, Tower 1, 841, Senapati ,Bapat Marg,Elphinstone Road,Mumbai-13
Contact Nos : 022 - 3099 4600
Fax : 022 - 3099 4699
Email : customer_care@reliancemutual.com
Website :  www.reliancemutual.com

Fund Manager Speak

Tushar Pradhan, CIO, HSBC Mutual Fund
“Our research shows that a disciplined approach to buying companies that look attractive on this matrix provides significant longer term outperformance.”..
Vikaas Sachdeva, CEO, Edelweiss Asset Management Ltd
Kaushik Dani, Head of Equity, Peerless Funds Management Company
View all Fund Manager Speak >>

IIFL Blogs

R. Venkataraman
The famous VDI scheme or Voluntary Disclosure of Income Scheme, allowed people to disclose their income, pay a tax on it and the names were kept confidential. It was a big ‘black to white’ conversi...
Anu Jain
Volatility was the name of the game last week on world markets - with PIIGS and Goldman Sachs causing downside triggers and strong internals of the US and Indian markets bringing in relief rallies ...